2 reports

  • DIAGNOSTIC TEST - PROSTATE CANCER
  • PROSTATE CANCER STRATIFICATION ASSAY

Summary ProteoMediX AG (ProteoMediX) is a medical diagnostic company that identifies and develops novel biomarkers for the early detection of cancer and the personalized treatment.The company develops non-invasive diagnostic tests for the detection, prognosis, stratification, and therapy-selection of prostate cancer. Its...

  • Cancer
  • Prostate Cancer
  • Switzerland
  • Company
  • ProteoMediX AG
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.